PAPER Bandiera S, Cartault F, Jannot AS, Hatem E, Girard M, Rifai L, Loiseau C, Munnich A, Lyonnet S, Henrion-Caude A
SEARCH RESULTS
330986 RESULTS
PAPER Ahn TB, Langston JW, Aachi VR, Dickson DW
Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease.
Am J Neurodegener Dis. 2012;1(1):49-59. PubMed: 23383381PAPER Ghidoni R, Paterlini A, Benussi L
Circulating progranulin as a biomarker for neurodegenerative diseases.
Am J Neurodegener Dis. 2012;1(2):180-90. PubMed: 23383391PAPER Perez PD, Hall G, Kimura T, Ren Y, Bailey RM, Lewis J, Febo M, Sahara N
In vivo functional brain mapping in a conditional mouse model of human tauopathy (tau(P301L)) reveals reduced neural activity in memory formation structures.
Mol Neurodegener. 2013;8:9. PubMed: 23379588PAPER Wickner RB, Edskes HK, Bateman DA, Kelly AC, Gorkovskiy A, Dayani Y, Zhou A
Amyloids and yeast prion biology.
Biochemistry. 2013 Mar 5;52(9):1514-27. PubMed: 23379365PAPER Honarnejad K, Jung CK, Lammich S, Arzberger T, Kretzschmar H, Herms J
Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease.
J Cell Mol Med. 2013 Feb;17(2):293-302. PubMed: 23379308PAPER Haldar S, Beveridge AJ, Wong J, Singh A, Galimberti D, Borroni B, Zhu X, Blevins J, Greenlee J, Perry G, Mukhopadhyay CK, Schmotzer C, Singh N
A Low-Molecular-Weight Ferroxidase Is Increased in the CSF of sCJD Cases: CSF Ferroxidase and Transferrin as Diagnostic Biomarkers for sCJD.
Antioxid Redox Signal. 2013 Apr 16; PubMed: 23379482PAPER Silva D, Chioua M, Samadi A, Agostinho P, Garção P, Lajarín-Cuesta R, de los Ríos C, Iriepa I, Moraleda I, Gonzalez-Lafuente L, Mendes E, Pérez C, Rodríguez-Franco MI, Marco-Contelles J, Carmo Carreiras M
Synthesis, Pharmacological Assessment, and Molecular Modeling of Acetylcholinesterase/Butyrylcholinesterase Inhibitors: Effect against Amyloid-β-Induced Neurotoxicity.
ACS Chem Neurosci. 2013 Apr 17;4(4):547-65. PubMed: 23379636PAPER Delbeuck X, Debachy B, Pasquier F, Moroni C
Action and noun fluency testing to distinguish between Alzheimer's disease and dementia with Lewy bodies.
J Clin Exp Neuropsychol. 2013 Mar;35(3):259-68. PubMed: 23379677PAPER Leal SL, Yassa MA
Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.
Ageing Res Rev. 2013 Feb 4; PubMed: 23380151PAPER Zhang R, Miller RG, Madison C, Jin X, Honrada R, Harris W, Katz J, Forshew DA, McGrath MS
Systemic immune system alterations in early stages of Alzheimer's disease.
J Neuroimmunol. 2013 Mar 15;256(1-2):38-42. Epub 2013 Feb 4 PubMed: 23380586PAPER Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, Frebourg T, Campion D, Hannequin D
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
J Alzheimers Dis. 2013;35(1):45-9. PubMed: 23380991PAPER Scahill RI, Ridgway GR, Bartlett JW, Barnes J, Ryan NS, Mead S, Beck J, Clarkson MJ, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC
Genetic Influences on Atrophy Patterns in Familial Alzheimer's Disease: A Comparison of APP and PSEN1 Mutations.
J Alzheimers Dis. 2013 Jan 1;35(1):199-212. PubMed: 23380992PAPER Merrill DA, Siddarth P, Kepe V, Raja PV, Saito N, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Small GW
Vascular Risk and FDDNP-PET Influence Cognitive Performance.
J Alzheimers Dis. 2013 Jan 1;35(1):147-57. PubMed: 23380994PAPER Walton JR
Aluminum involvement in the progression of Alzheimer's disease.
J Alzheimers Dis. 2013 Jan 1;35(1):7-43. PubMed: 23380995Current Filters
No filters selected